Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan G Kermode

Showing results (61-70 of 120) with videos related to

Pageof 12
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2010
Low level of systemic autoimmunity in Western Australian multiple sclerosis patientsWei Qiu, Christine Bundell, Jing-Shan Wu, et al.
Neuroscience Bulletin|May 2, 2019
Myelin Oligodendrocyte Glycoprotein-IgG Contributes to Oligodendrocytopathy in the Presence of Complement, Distinct from Astrocytopathy Induced by AQP4-IgGLing Fang, Xinmei Kang, Zhen Wang, et al.
Journal of Neuroimmunology|June 4, 2013
IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosisWen Xu, Rui Li, Yongqiang Dai, et al.
Plos One|February 6, 2016
Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis PathogenesisMonika Tschochner, Shay Leary, Don Cooper, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 21, 2015
Helicobacter pylori infection as a protective factor against multiple sclerosis risk in femalesMarzena J Fabis Pedrini, Alexandra Seewann, Kirsten A Bennett, et al.
Multiple Sclerosis and Related Disorders|January 30, 2026
Elevated serum complement shows promise as a potential clinically practical biomarker for disease activity in myelin oligodendrocyte glycoprotein antibody-associated disordersYiying Huang, Linling Wang, Marzena Fabis-Pedrini, et al.
Journal of Neurology|July 2, 2021
NMOSD and MS prevalence in the Indigenous populations of Australia and New ZealandWajih Bukhari, Elham Khalilidehkordi, Deborah F Mason, et al.
Frontiers in Immunology|June 18, 2020
Different Exosomal microRNA Profile in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum DisordersChen Chen, Yunting Wu, Miaochang Li, et al.
Journal of the Neurological Sciences|March 25, 2018
Study of the placentae of patients with neuromyelitis optica spectrum disorderYanyu Chang, Yaqing Shu, Xiaobo Sun, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 14, 2022
Clinical and genetic analysis of familial neuromyelitis optica spectrum disorder in Chinese: associated with <i>ubiquitin-specific peptidase USP18</i> gene variantsYanyu Chang, Luyao Zhou, Xiaonan Zhong, et al.
Pageof 12

Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2010
Low level of systemic autoimmunity in Western Australian multiple sclerosis patientsWei Qiu, Christine Bundell, Jing-Shan Wu, et al.
Neuroscience Bulletin|May 2, 2019
Myelin Oligodendrocyte Glycoprotein-IgG Contributes to Oligodendrocytopathy in the Presence of Complement, Distinct from Astrocytopathy Induced by AQP4-IgGLing Fang, Xinmei Kang, Zhen Wang, et al.
Journal of Neuroimmunology|June 4, 2013
IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosisWen Xu, Rui Li, Yongqiang Dai, et al.
Plos One|February 6, 2016
Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis PathogenesisMonika Tschochner, Shay Leary, Don Cooper, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 21, 2015
Helicobacter pylori infection as a protective factor against multiple sclerosis risk in femalesMarzena J Fabis Pedrini, Alexandra Seewann, Kirsten A Bennett, et al.
Multiple Sclerosis and Related Disorders|January 30, 2026
Elevated serum complement shows promise as a potential clinically practical biomarker for disease activity in myelin oligodendrocyte glycoprotein antibody-associated disordersYiying Huang, Linling Wang, Marzena Fabis-Pedrini, et al.
Journal of Neurology|July 2, 2021
NMOSD and MS prevalence in the Indigenous populations of Australia and New ZealandWajih Bukhari, Elham Khalilidehkordi, Deborah F Mason, et al.
Frontiers in Immunology|June 18, 2020
Different Exosomal microRNA Profile in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum DisordersChen Chen, Yunting Wu, Miaochang Li, et al.
Journal of the Neurological Sciences|March 25, 2018
Study of the placentae of patients with neuromyelitis optica spectrum disorderYanyu Chang, Yaqing Shu, Xiaobo Sun, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 14, 2022
Clinical and genetic analysis of familial neuromyelitis optica spectrum disorder in Chinese: associated with <i>ubiquitin-specific peptidase USP18</i> gene variantsYanyu Chang, Luyao Zhou, Xiaonan Zhong, et al.
Pageof 12